Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Lord Abbett & CO. LLC

Lord Abbett & CO. LLC lowered its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 0.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 76,030 shares of the company’s stock after selling 550 shares during the quarter. Lord Abbett & CO. LLC’s holdings in Addus HomeCare were worth $9,530,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of ADUS. JPMorgan Chase & Co. raised its position in shares of Addus HomeCare by 10.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock valued at $24,371,000 after acquiring an additional 16,997 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares during the period. Cherry Creek Investment Advisors Inc. bought a new position in shares of Addus HomeCare in the 4th quarter worth about $340,000. Amundi boosted its holdings in shares of Addus HomeCare by 185.9% in the 4th quarter. Amundi now owns 9,008 shares of the company’s stock valued at $1,139,000 after buying an additional 5,857 shares during the period. Finally, Barclays PLC boosted its holdings in shares of Addus HomeCare by 204.8% in the 3rd quarter. Barclays PLC now owns 43,470 shares of the company’s stock valued at $5,783,000 after buying an additional 29,207 shares during the period. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Up 1.0 %

Shares of ADUS opened at $100.58 on Friday. The firm has a market capitalization of $1.83 billion, a PE ratio of 23.02, a P/E/G ratio of 1.41 and a beta of 0.93. The firm has a 50-day moving average price of $97.93 and a 200 day moving average price of $116.06. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. On average, equities analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analyst Ratings Changes

ADUS has been the topic of a number of recent research reports. Stephens reissued an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Oppenheimer upped their price objective on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Macquarie reiterated an “outperform” rating and issued a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. Finally, JMP Securities reissued a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a report on Tuesday, April 22nd. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Addus HomeCare presently has an average rating of “Buy” and a consensus price target of $139.00.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.